🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for T-Cell Large Granular Lymphocyte Leukemia

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia NCT05863234Phase 1, Phase 21 site📍 Hiroshima Hiroshima University Hospital · Tests: PPMX-T003 Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia NCT05592015Phase 23 sites📍 Boston📍 New York📍 Columbus Jonathan Brammer · Tests: Ruxolitinib JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06716658Phase 22 sites📍 Tianjin📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: JAK1 Inhibitor Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases NCT07727083n/a1 site📍 Shanghai Rong Tao Registry of the German CLL Study Group NCT02863692n/a1 site📍 Dresden German CLL Study Group A Study of Ruxolitinib and Duvelisib in People With Lymphoma NCT05010005Phase 19 sites📍 Miami📍 Boston📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Ruxolitinib, Duvelisib PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06530550Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: PI3K inhibitor National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia NCT07019766n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: A combined retrospective and prospective observational follow-up A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites📍 Duarte📍 San Diego📍 San Francisco Memorial Sloan Kettering Cancer Center · Tests: Optional Blood Sample and Nail Sample National Longitudinal Cohort of Hematological Diseases NCT04645199n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas NCT05475925Phase 1, Phase 237 sites📍 Birmingham📍 Duarte📍 Irvine Dren Bio · Tests: DR-01 Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia NCT06530576Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Thalidomide and methotrexate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy